Skip to content

Randomized Cross-over TRD and CPAP for OSA

A Randomized Cross-over Study of Tongue Retaining Device and Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02788487
Enrollment
36
Registered
2016-06-02
Start date
2016-01-31
Completion date
2017-05-31
Last updated
2016-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

The objectives of this study is to compare short-term outcomes of CPAP and TRD in the treatment of obstructive sleep apnea. Study design is a randomized cross-over trial during 3-weeks period of each treatment in 36 patients. Primary outcomes are quality of life, degree of sleepiness, and severity of OSA determined by FOSQ ESS, and AHI or RDI, respectively.

Detailed description

The objectives of this study is to compare short-term outcomes of CPAP and TRD in the treatment of obstructive sleep apnea. Study design is a randomized cross-over trial during 3-weeks period of each treatment in 36 patients. Primary outcomes are quality of life, degree of sleepiness, and severity of OSA determined by FOSQ ESS, and AHI or RDI, respectively. Wash-in period 1 week and Wash-out periods 1 week are required before start each treatment.

Interventions

DEVICETongue retaining device

Tongue retaining device is used for 3 weeks

DEVICECPAP

CPAP is used for 3 weeks

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. OSA patients aged over 18 years old at Siriraj hospital 2. Apnea-hypopnea index (AHI) 5 - 30 events/ h or AHI \> 30 events/h but lowest Oxygen saturation \> 70% 3. Positive consented form

Exclusion criteria

1. Patients with severe periodontal diseases 2. Patients with unstable medical problems i.e. poorly controlled cardiovascular diseases, cancers, cerebrovascular diseases, epilepsy, dementia, etc. 3. total sleep time less than 2 hour during previous sleep study 4. Patients who could not tolerate the side effects of CPAP or TRD 5. Patients who could not follow-up until finishing the protocol or withdraw themselves from the study for any reasons.

Design outcomes

Primary

MeasureTime frame
apnea-hypopnea index (AHI)3 weeks

Secondary

MeasureTime frame
Functional outcomes of sleep questionnaire (FOSQ ) score3 weeks
Epworth sleepiness score (ESS) scores3 weeks
lowest oxygen saturation during sleep test at home3 weeks
side effects questionnaire3 weeks
satisfaction and preference of device questionnaire3 weeks

Countries

Thailand

Contacts

Primary ContactWish - Banhiran, MD
wishbanh@hotmail.com6699756405
Backup ContactAnuch - Durongphan, MD
anuch.mai@gmail.com662 419 8040

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026